Jpmorgan Chase & CO Sensus Healthcare, Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 3,898 shares of SRTS stock, worth $22,764. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,898Holding current value
$22,764% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SRTS
# of Institutions
70Shares Held
4.9MCall Options Held
31.2KPut Options Held
2.1K-
Vanguard Group Inc Valley Forge, PA740KShares$4.32 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny431KShares$2.52 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX379KShares$2.21 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA348KShares$2.03 Million0.01% of portfolio
-
Morgan Stanley New York, NY249KShares$1.46 Million0.0% of portfolio
About Sensus Healthcare, Inc.
- Ticker SRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,556,000
- Market Cap $96.7M
- Description
- Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...